Protective effects of Spirulina on the liver function and hyperlipidemia of rats and human

Brazilian Archives of Biology and Technology

Volumn 57, Issue 1, 2014, Pages 77-86

  El Sheekh, Mostafa Mohamed ^a   Hamad, Saied Mohamed ^b   Gomaa, Mahmoud ^a  

^a Tanta University   (Egypt)

^b TANTA UNIVERSITY   (Egypt)

Author keywords

Hyperlipidemia; Liver functions; Protective effects; Spirulina

Indexed keywords

EID: 84895103294     PISSN: 15168913     EISSN: 16784324     Source Type: Journal    
DOI: 10.1590/S1516-89132014000100012     Document Type: Article

References (43)

1. Adams LA, Talwalkar, J.A. Diagnostic evaluation of nonalcoholic fatty liver disease, J Clin Gastroenterol. 2006; 40: 34-65.
2. Altlparmak E, Koklu S, Yallnklllc M, Yuksel O, Cicek B, Kayacetin E, Sahin, T. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol. 2005; 11: 3056-3059.
3. Babadzhanov AS, Abdusamatova N, Yusupova FM, Faizullaeva N, Mezhlumyan LG, Malikova MK. Chemical composition of Spirulina platensis cultivated in uzbekistan. Chem Natur Comp. 2004; 40(3): 276-279.
4. Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician. 2006, 73 (11): 1961-1968.
5. Becker EW, Jakober B, Luft D. Clinical and biochemical evaluations of the alga Spirulina with regard to its application in the treatment of obesity. A double-blind cross over study. Nutr Rep Intern.1986; 33:565-573.
6. Belay A. The potential application of Spirulina (Arthrospira) as a nutritional and therapeutic supplement in health management. J Am Nutraceut Assoc. 2002; 5(2): 27-48.
7. Boekholdt SM. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J AmerNutraceutAssoc. 2007; 49: 547-533.
8. Buccolo G, David H. Quantitative determination of serum triglycerides by use enzymes. Clin Chem. 1973; 19 (5): 476-482.
9. Burstein M, Scholnick, H.R., Morfin, R. Severe combined hyperlipidemia. Scand J Clin Lab Invest. 1980; 40: 560-572.
10. Burtis A. Clinical and experimental study of Spirulina. Tietz Textbook of Clinical Chemistry, 1999; 3rd ed AACC.
11. Carroll MD, Lacher DA, Sorlie PD, Cleeman, JI, Gordon DJ, Wolz, M, Grundy SM, Johnson CL. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005; 294(14): 1773-1781.
12. Chen LL, Ble-Castillo JL, Juarez-Oropeza MA, Diaz-Zagoya JC. Experimental study of Spirulina platensis in treating allergic rhinitis in rats. J Central South Univ (Medical Sciences) 2005; 30(1): 96-98.
13. Doherty JF, Golden, MH, Brooks SE: Peroxisomes and the fatty liver of malnutrition: A hypothesis. Am J Clin Nutr. 1991; 54: 674.
14. Finley PR, Schifman RB, Williams RJ, Lichti DA: Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. Clin Chem. 1978; 24: 931-933.
15. Fischbach F, Zawta B. Age-dependent reference limits of several enzymes in plasma at different measurement temperatures. Klin Lab. 1992; 38: 555-561.
16. González de Rivera C, Miranda-Zamora R, Díaz-Zagoya JC, Juárez-Oropeza MA. Preventive effect of Spirulina maxima on the fatty liver induced by a fructose-rich diet in the rat, a preliminary report. OrigRes Article Life Sci. 1993; 53 (1): 57-61.
17. Guha-Mazumder DN: Arsenic and liver disease, J Ind Medic Assoc. 2001, 9: 311-324.
18. Huang Z, Guo BJ, Wong RNS, Jiang Y. Characterization and antioxidant activity of selenium-containing phycocyanin isolated from Spirulina platensis. Food Chem. 2007; 100(3): 1137-1143.
19. James, WD, Berger G, Timothy G. Andrews' Diseases of the Skin: clinical Dermatology, 2 nd edition, 2006.
20. Juárez-Oropeza MA, Mascher D, Torres-Durán PV, Farias JM, Paredes-Carbajal MC. Effects of dietary Spirulina on vascular reactivity. J Med Food. 2009; 12(1): 15-20
21. Khan M, Shobha JC, Mohan IK, Naidu MU, Sundaram C, Singh S, Kuppusamy P, Kutala VK. Protective effect of Spirulina against doxorubicininduced cardiotoxicity. Photother Res. 2005; 19(12): 1030-1047.
22. Kulshreshtha A, Zacharia AJ, Jarouliya U, Bhadauriya P, Prasad GB, Bisen PS. Spirulina in health care management. Curr Pharmaceut Biotechnol. 2008; 9 (5): 400-405.
23. Lee YK. Commercial production of microalgae in the Asia-Pacific rim. J Appl Phycol. 1997; 9: 403-411.
24. Lewington S, Whitlock, G., Clarke, R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007; 370:1829-1842.
25. Malloy HT, Evelyn KA. The determination of bilirubin with the photoelectric colorimeter. J Biol Chem. 1937; 119: 481-490.
26. Nakaya N, Homma Y, Goto Y. Cholesterol lowering effect of Spirulina. Nutr Rep Intern. 1988; 37:1329-37.
27. Rader, DJ, Hoeg JM, Brewer HB. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Annals Internal Medicine. 1994; 120:1012-1033.
28. Reddy JK, Rao MS. Lipid metabolism and liver inflammation, Fatty liver disease and fatty acid oxidation. Amer J Physiol - Gastroint Liver. 2006; 290 (5): 852-858.
29. Riely CA. Acute fatty liver of pregnancy. Semin Liver Dis. 1987; 7(1): 47-54.
30. Rodkey FL. Tris (hydroxymethyl) Aminomethane as a standard for kjeldahl nitrogen analysis. Clin Chem. 1964; 10: 606-610.
31. Sánchez M. Spirulina (Arthrospira): An edible microorganism, a review 2007; http://www.javeriana.edu.co/universitas_scientiarum/vol8n1/J_bernal.htm.
32. Schumann G, Bonora R, Ceriotti F. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine, Part-5, Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase. Clin Chem Lab Med. 2002; 40: 725-733.
33. Schumann G, Klauke R. New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clinica Chim Acta. 2003; 327: 69-79.
34. Shattat G, Al-Qirim T, Sweidan K, Shahwan M, El-Huneidi W, Al-Hiari Y. The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate. J Enzyme Inhibit Medic Chem. 2010, 25(6): 751-755
35. Tokusoglu O, Uunal MK. Biomass Nutrient Profiles of three Microalgae: Spirulina platensis, Chlorella vulgaris, and Isochrisis galbana. J Food Science. 2003; 68 (4): 1144-1148.
36. Torres-Duran PV, Hermosillo F, Oropeza J. Antihyperlipidemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: A preliminary report. Lipids Health Dis. 2007; 6: 33-49.
37. Torres-Duran PV, Miranda-Zamora R, Paredes-Carbajal MC, Mascher D, Diaz-Zagoya JC, Oropeza J. Studies on the preventive effect of Spirulina maxima on fatty liver development induced by carbon tetrachloride in the rat. J Ethnopharmacol. 1999; 64 (2): 141-147.
38. Vonshak A. Spirulina platensis (Arthrospira), Physiology, Cell-biology and Biotechnology. 1997; London: Taylor & Francis.
39. Walters MI, Gerarde H. Pharmaceutical chemistry, Volume 2. Microchem J. 1970; 15(1): 150-155.
40. Wang Y, Chang C, Chou J, Chen H, Deng X, Harvey BK, Cadet JL, Bickford PC. Dietary supplementation with blueberries, spinach, or Spirulina reduces ischemic brain damage. Experim Neurol. 2005; 193(1): 75-84.
41. Wu LL, Warnick GR, Wu JT, Williams RR, Lalouel JM. A rapid micro-scale procedure for determination of the total lipid profile. Clin Chem. 1989; 35: 1486-1491.
42. Young DS: Effects of disease on Clinical Lab. Tests 2001, 4th ed AACC.
43. Zarrouk C. Contribution a l etude d une cyanophycee influence dedivers facteurs physiques et chimiques sur la croissance et photosynthese de Spirulina maxima. Geither, Nutr Diet. 1966; 77: 32-46.